A comprehensive view of Moderna Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

David Rubenstein joins Moderna's Board of Directors, replacing Stephen Berenson; Robert Langer also retiring from the board, recruitment for his replacement ongoing
Published: July 23, 2024 by Moderna Inc.
Moderna addresses 'triple demic' threat of RSV, flu, COVID-19; company educates on mRNA's role in vaccine innovation through webinars, blog posts
Published: July 19, 2024 by Industry Intelligence Inc.
Moderna to report Q2 2024 financial results on August 1, 2024; company to host live conference call and webcast at 8:00 a.m. ET
Published: July 10, 2024 by Moderna Inc.
Moderna and Mitsubishi Tanabe Pharma to promote mRNA respiratory vaccines in Japan, including COVID-19; agreement valid until March 31, 2029, covers manufacturing, sales, and distribution
Published: July 08, 2024 by Moderna Inc.
Moderna Inc. expands biotech leadership with strategic presence at UK's Harwell Science and Innovation Campus; initiative includes constructing Moderna Innovation and Technology Centre
Published: July 05, 2024 by Industry Intelligence Inc.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count